DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Tanna AP, Johnson M.
Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension.
Ophthalmology 2018;
125: 1741-1756
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.